Clark Capital Management Group, Inc. Halozyme Therapeutics, Inc. Transaction History
Clark Capital Management Group, Inc.
- $13.4 Billion
- Q1 2025
A detailed history of Clark Capital Management Group, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 205,762 shares of HALO stock, worth $12.4 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
205,762
Previous 178,827
15.06%
Holding current value
$12.4 Million
Previous $8.55 Million
53.57%
% of portfolio
0.1%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding HALO
# of Institutions
583Shares Held
122MCall Options Held
308KPut Options Held
131K-
Black Rock Inc. New York, NY17.6MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$771 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$364 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$234 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$221 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.37B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...